A Multicenter, Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 2 Clinical Trial to Evaluate the Efficacy in Reduction of Intraocular Pressure and Safety of PHP-201 in Patients With Normal Tension Glaucoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2018
At a glance
- Drugs PHP 201 (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 04 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 May 2018.
- 04 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.
- 04 Apr 2018 Status changed from recruiting to active, no longer recruiting.